Market Overview
The global avenanthramides market is estimated at USD 145.1 million in 2025 and is projected to reach USD 295.0 million by 2033, reflecting a compound annual growth rate of approximately 9.5%. Avenanthramides are a family of hydroxycinnamic acid amides found predominantly in oats (Avena sativa) and are prized for their antioxidant, anti-inflammatory, and skin-soothing properties. They are typically supplied as oat-kernel extracts and incorporated into cosmetic formulations, dietary supplements, functional foods, and pharmaceutical preparations.
- •Market size of USD 145.1 million in 2025, expanding at a 9.5% CAGR toward 2033.
- •Primary botanical source is oats, with the compound class first identified in Avena sativa.
- •Used across cosmetics, nutraceuticals, functional foods, and pharmaceutical applications.
Growth Drivers
Consumer preference for naturally sourced, plant-based ingredients is the principal growth catalyst, particularly as brands reformulate products to meet clean-label and sustainability expectations. Rising investment in preventive health and wellness, alongside growing scientific evidence supporting avenanthramides' anti-inflammatory and skin-barrier benefits, is widening their use in cosmeceuticals and supplements. Additionally, expanding applications in functional foods and ongoing pharmaceutical research into chronic inflammatory conditions are opening new revenue streams.
- •Clean-label and natural ingredient trends in cosmetics and personal care are lifting demand.
- •Increased R&D investment is validating anti-inflammatory and skin-protective claims.
- •Functional food and pharmaceutical applications are extending addressable end-markets.
Segmentation and Regional Analysis
The market is commonly segmented by source (natural versus synthetic), form, application, and geography. The natural avenanthramides sub-segment generated approximately USD 9.8 million in 2025 and is growing at a faster 10.2% CAGR, while the pharmaceuticals end-use segment is valued at USD 37.4 million in 2025 with a 9.9% CAGR. North America and Europe lead on the back of mature cosmetics and nutraceutical industries, whereas Asia-Pacific, and notably India (valued at USD 4.07 million in 2025 with a 9.8% CAGR through 2034), represents the fastest-growing regional opportunity due to rising disposable incomes and expanding personal-care manufacturing.
- •Natural-source segment is growing faster (10.2% CAGR) than the overall market.
- •Pharmaceuticals end-use segment reached USD 37.4 million in 2025.
- •India is the most prominent emerging national market at USD 4.07 million in 2025 with a 9.8% CAGR.
Trends and Outlook
What are the recent trends and outlook?
Sustainability is reshaping sourcing strategies, with suppliers investing in upcycled oat fractions from cereal processing and regenerative agriculture programs to appeal to environmentally conscious buyers. Clinical and cosmeceutical research is expected to broaden approved health and beauty claims, supporting premium pricing in skincare and wellness applications. Looking ahead, the market is positioned to outpace the broader natural cosmetics category (projected 6.35% CAGR through 2030) and the cosmetic antioxidants segment (5% CAGR through 2030), reflecting the specific appeal of avenanthramides' well-documented anti-inflammatory activity.
- •Upcycled and traceable oat sourcing is becoming a procurement differentiator.
- •Avenanthramides are forecast to grow roughly twice as fast as the wider cosmetic antioxidants category.
- •New clinical evidence is likely to unlock additional cosmeceutical and therapeutic applications.
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.